Author:
Ogawa Hiroyasu,Ikegame Kazuhiro,Kawakami Manabu,Takahashi Satoshi,Sakamaki Hisashi,Karasuno Takahiro,Sao Hiroshi,Kodera Yoshihisa,Hirabayashi Noriyuki,Okamoto Shinichiro,Harada Mine,Iwato Koji,Maruta Atsuo,Tanimoto Mitsune,Kawa Keisei
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Hann IM, Stevens RF, Goldstone AH, et al. Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia: results of the Medical Research Council's 10th AML Trial (MRC AML 10). Blood. 1997;89:2311-2318.
2. Mayer RJ, Davis RB, Schiffer CA, et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N Engl J Med. 1994;331:896-903.
3. Zittoun R, Jehn U, Fiere C, et al. Alternating repeated postremission treatment in adult acute myelogenous leukemia: a randomized phase III study (AML6) of the EORTC Leukemia Cooperative Group. Blood. 1989;73:896-906.
4. Cassileth PA, Harrington DP, Hines JD, et al. Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia. J Clin Oncol. 1988;6:583-587.
5. Burnett AK, Goldstone AH, Stevens RMF, et al. Randomized comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. Lancet. 1998;351:700-708.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献